thyroid cancer. Malignant neoplasm of thyroid gland
Conditions
Interventions
Intervention 1: Intervention group 1: The group received one capsule containing 500 mg of Korean Ginseng (Panax Ginseng) from Isfahan Ponic Medicines Company, completely herbal with no chemical additi
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients between the ages of 30 and 60 who had thyroid cancer and underwent thyroid surgery. Patients who first receive radioactive iodine.
Exclusion criteria
Exclusion criteria: People who have undergone radiotherapy or chemotherapy in the last year. People with certain genetic diseases. People taking medications for heart and kidney failure, and those who take Warfarin anticoagulants definitively. People who smoke. People who are radiant People who have taken ginseng in the last month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of micronuclei in lymphocytes of patients. Timepoint: At baseline (before intervention) and 48 hours after treatment. Method of measurement: Examination of lymphocytes of patients under the microscope after laboratory procedures. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA 96 kit.;Ischemic modified albumin. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method.;The rate of malondialdehyde production in the process of oxidative stress. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method.;Evaluation of hepatic Alanine transaminase. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method.;Evaluation of hepatic enzyme Aspartate aminotransferase. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method.;Blood urea nitrogen test. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method.;Evaluation of Creatinine level. Timepoint: Before treatment and 48 hours after treatment. Method of measurement: Using the ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Reza fardid
Shiraz University of Medical Sciences
Outcome results
None listed